INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS
-
What To Look For In A Cell Culture Media Supplier
Choosing a cell culture media supplier is crucial in biopharmaceutical manufacturing. Explore five key factors to take into account when choosing a supplier and evaluating their capabilities.
-
Lilly's Unified Mindset For A Global Parenteral and Device Manufacturing Network
Eli Lilly and Company's one-team mindset aims to templatize facility design while remaining nimble enough to react to new manufacturing breakthroughs.
-
CAR T Cell Generation From Cryopreserved Leukapheresis Products
A seven‑day CAR T cell manufacturing workflow shows how cryopreserved leukapheresis material can deliver high viability and strong antitumor activity, offering a more flexible path for production.
-
The Help You Need- Available Where And How You Need It
Flexible lab equipment services covering maintenance, repair, qualification, and validation to improve reliability, compliance, and operational efficiency.
-
Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview
From lab to production scale: a researcher's firsthand account of what bioreactor scaling and high-density perfusion really demand in practice.
-
How MacroGenics Increased mAb Titers By Up To 80% In Scale-Up
Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing.
-
Master The Art Of Pipetting And Learn How To Perform Serial Dilutions
Accurate serial dilutions depend on more than calculations. Learn how mixing, tip handling, and workflow consistency influence accuracy, as well as how small adjustments can improve reproducibility.
-
Field Notes: APEC RHSC's Workshop On ATMP Development And Evaluation
Scientific and regulatory leaders in the Asia-Pacific region met recently for an exchange of strategies to strengthen convergence and technical competence.
-
U.S. Pharma Tariffs And MFN Become Law After April 2 Update
Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
-
Industrializing Cell Therapy With Perfusion
Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.